Health Trials

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

ConditionsMajor Depressive Disorder (MDD)Treatment Resistant Depression (TRD)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCharles University, Czech Republic

About this trial

The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy

Eligibility criteria

Qualifiers

Age equal to 18 or higher

MADRS (Montgomery-Asberg Depression Scale) qual or higher than 20

Major depressive disorder according to ICD 10

Disqualifiers

Other axis 1 disorder (for example schizofrenia, addiction, etc.)

No dementia

ECT in the last 3 months

TMS in the last 3 months

Trial design

Treatments tested in this trial

  • Electroconvulsive therapy
  • Transcranial Magnetic Stimulation

Treatment groups

50 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Charles University, Czech Republic

Lead sponsor

Source ClinicalTrials.gov